About Sware
Sware is a company based in Chelsea (United States) founded in 2015 by Kosal Keo. Sware has raised $24.37 million across 4 funding rounds from investors including First Analysis, LRVHealth and New Stack Ventures. Sware offers products and services including Res_Q and GxPNext. Sware operates in a competitive market with competitors including RIMSYS, ValGenesis, Virtify, 3Aware and Essenvia, among others.
- Headquarter Chelsea, United States
- Founders Kosal Keo
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sware, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$24.37 M (USD)
in 4 rounds
-
Latest Funding Round
$6.02 M (USD), Series B
Apr 17, 2024
-
Investors
First Analysis
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sware
Sware offers a comprehensive portfolio of products and services, including Res_Q and GxPNext.
Automates GxP validation processes to reduce costs and ensure compliance
Manages GxP requirements for life sciences through unified platforms
Funding Insights of Sware
Sware has successfully raised a total of $24.37M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $6.02 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Sware
Sware has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include First Analysis, LRVHealth and New Stack Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital and transaction advisory services for B2B tech companies.
|
Locked | Locked | Locked | |
|
Early stage venture capital firm investing in the US
|
Locked | Locked | Locked | |
|
Early-stage venture capital investments are made in innovative startups.
|
Locked | Locked | Locked |
Investor details for Sware
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sware
Investment portfolio details for Sware
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sware
Detailed financials for Sware
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sware Comparisons
Peer comparison for Sware
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sware
Sware operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as RIMSYS, ValGenesis, Virtify, 3Aware and Essenvia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Medical device regulatory management software is provided for healthcare organizations.
|
|
| Locked | Locked | Locked |
Validation software is provided for life sciences companies.
|
|
| Locked | Locked | Locked |
Delivers content and compliance management software solutions.
|
|
| Locked | Locked | Locked |
Provider of real-world evidence platform for MedTech device safety and performance
|
|
| Locked | Locked | Locked |
Software for medical device pre- and post-market workflows is provided.
|
Detailed competitors of Sware
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sware
Complete news archive for Sware
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sware
Sware was founded in 2015 and raised its 1st funding round 5 years after it was founded.
Sware is headquartered in Chelsea, United States. It is registered at Chelsea, Massachusetts, United States.
Bryan Ennis is the current CEO of Sware.
Sware is a funded company, having raised a total of $24.37M across 4 funding rounds to date.
A platform for validation automation in regulated systems was established in 2015 and is based in Chelsea, United States. Operations focus on the compliance technology sector, where the Res_Q system is utilized for lifecycle management and workflow automation. Compliance with regulated technology solutions is managed through these tools, supporting industries requiring strict validation protocols. Leadership includes a founder and CEO guiding development.
Sware's top competitors include RIMSYS, ValGenesis and 3Aware.
Sware offers Res_Q and GxPNext.
Sware has 5 investors. Key investors include First Analysis, LRVHealth, New Stack Ventures, Insight Partners, and Jumpstart Foundry.